All News Roche Holding AG

Equities

ROG

CH0012032048

Market Closed - Swiss Exchange Other stock markets 11:31:35 2024-06-07 am EDT			5-day change	1st Jan Change
242.6 ^CHF	+1.89%		+5.02%	-0.78%

05:14pm	Roche: efficacy of Evrysdi in spinal muscular atrophy	CF
05:12pm	Roche's Five-year Data Confirms Efficacy, Safety of Evrysdi Drug for Spinal Muscular Atrophy in Children	MT

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Roche: efficacy of Evrysdi in spinal muscular atrophy	11:14am	CF
Roche's Five-year Data Confirms Efficacy, Safety of Evrysdi Drug for Spinal Muscular Atrophy in Children	11:12am	MT
Five-year Data for Genentech’s Evrysdi Show the Majority of Treated Children With a Severe Form of Spinal Muscular Atrophy (SMA) Achieved or Maintained the Ability to Sit, Stand or Walk	10:41am	BU
Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug	12:43am	MT
AlphaValue/Baader Europe Lifts Price Target on Roche, Maintains Buy Recommendation	Jun. 06	MT
Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe	Jun. 06	DJ
The odds of rates getting cut in 2024 may be better than you think	Jun. 05
ROCHE HOLDINGS AG : Deutsche Bank reiterates its Neutral rating	Jun. 03	ZD
ROCHE HOLDINGS AG : Goldman Sachs reaffirms its Sell rating	Jun. 03	ZD
Astra's Enhertu breast cancer trial shows 'unprecedented' results	Jun. 02	RE
Astra's Enhertu delays breast cancer in patients with low HER2 levels	Jun. 02	RE
ROCHE HOLDINGS AG : Gets a Neutral rating from UBS	May. 31	ZD
Transcript : Roche Holding AG - Shareholder/Analyst Call	May. 31
ROCHE HOLDINGS AG : Goldman Sachs remains a Sell rating	May. 30	ZD
Swiss Stocks Fall as Rate Jitters Intensify Amid Latest Inflation Data	May. 29	MT
Global markets live: BHP, Anglo American, Lenovo, Nvidia, Apple...	May. 29
European Midday Briefing : Mood Sours as Fed Rate-Cut Bets Curtailed	May. 29	DJ
Roche: FDA grants priority review in breast cancer	May. 29	CF
Roche's Metastatic Breast Cancer Treatment Granted Priority Review by US FDA	May. 29	MT
Roche Breast-Cancer Drug Gets Priority Review in the U.S.	May. 29	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 11:50 am EDT

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am EST